tiprankstipranks
ProMIS Neurosciences reports Q2 EPS (13c) vs (27c) last year
PremiumThe FlyProMIS Neurosciences reports Q2 EPS (13c) vs (27c) last year
5M ago
ProMIS Neurosciences annouces data on pathogenic role of misfolded SOD1
Premium
The Fly
ProMIS Neurosciences annouces data on pathogenic role of misfolded SOD1
5M ago
ProMIS Neurosciences presents preclinical data on ABO at AAIC
Premium
The Fly
ProMIS Neurosciences presents preclinical data on ABO at AAIC
5M ago
ProMIS Neurosciences publishes study highlighting oligomers in journal bioRxiv
PremiumThe FlyProMIS Neurosciences publishes study highlighting oligomers in journal bioRxiv
8M ago
ProMIS  publishes data on pathogenic proteins as treatment target for ALS
Premium
The Fly
ProMIS publishes data on pathogenic proteins as treatment target for ALS
9M ago
ProMIS Neurosciences strengthens global IP portfolio
Premium
The Fly
ProMIS Neurosciences strengthens global IP portfolio
10M ago
ProMIS Neurosciences doses first subjects in Phase 1a trial of PMN310
PremiumThe FlyProMIS Neurosciences doses first subjects in Phase 1a trial of PMN310
1y ago
ProMIS Neurosciences initiated with a Buy at BTIG
Premium
The Fly
ProMIS Neurosciences initiated with a Buy at BTIG
1y ago
ProMIS Neurosciences files $100M mixed securities shelf
Premium
The Fly
ProMIS Neurosciences files $100M mixed securities shelf
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100